Esiti precoci dell'ossigenazione extracorporea a membrana per la chirurgia cardiaca congenita.

OBJECTIVES: Extracorporeal membrane oxygenation is widely used to treat cardiopulmonary failure after congenital heart surgery. This study evaluated patient characteristics, outcomes, and risk factors associated with perioperative veno-arterial extracorporeal membrane oxygenation use. METHODS: All patients undergoing congenital heart surgery between 2001 and 2024 at our centre were included. Prevalence, outcomes, risk factors for extracorporeal membrane oxygenation support, and predictors of in-hospital mortality following extracorporeal membrane oxygenation were analysed. RESULTS: Among 9892 congenital heart operations, extracorporeal membrane oxygenation was required in 178 (1.8%) patien